Neovascularization in Human Atherosclerosis

In the absence of disease, the vasa vasorum nurture the outer component of the vessel wall, and the intima is fed by oxygen diffusion from the lumen. As disease progresses, the intima thickens, and oxygen diffusion is impaired. As a result, vasa become the major source for nutrients to the vessel wall.1 The vasa vasorum structure consists of a network of small arteries and veins, as shown in Figure 1. In the coronary arteries, vasa originate from bifurcation segments of epicardial vessels; in the ascending aorta, vasa originate from coronary and brachiocephalic arteries; and in the descending thoracic aorta, vasa originate from intercostal, lumbar, and mesenteric arteries.1 Figure 1. A, Volume-rendered high-resolution, 3-dimensional micro-CT image of the descending aorta vasa vasorum. B and C, Corresponding histological cross sections demonstrate atherosclerotic lesions in the inferior vena cava (black arrow). D, Highlighted differentiated arterial (red) and venous (blue) vasa vasorum. Masson trichrome stain; bar=500 μm. Reproduced with permission from Langheinrich AC, Michniewicz A, Sedding DG, Walker G, Beighley PE, Rau WS, Bohle RM, Ritman EL. Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(−/−)/low-density lipoprotein(−/−) double knockout mice. Arterioscler Thromb Vasc Biol . 2006;26:347–352. Copyright 2006, American Heart Association. Sympathetic fibers help vasa to regulate blood flow, as shown in Figure 2. Vasa react to adenosine and endothelin-1.2,3 However, vasa appear to be relatively insensitive to thromboxane A2, norepinephrine, and angiotensin II, providing neuronal protection against ischemia during sustained sympathetic activity.3 The vasa vasorum are also sensitive to acetylcholine, histamine, isoprenaline, adenosine triphosphate, adenosine diphosphate, adenosine, and sodium nitroprusside.4 Additionally, precontracted vasa exhibit endothelium-dependent vasodilatation to bradykinin and substance P, which are mediated by endothelium-dependent hyperpolarization and nitric oxide, respectively.4 As a result, vasa response to some agonists …

[1]  D. Haskard,et al.  Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery , 2004, Circulation research.

[2]  V. Fuster,et al.  Intimomedial Interface Damage and Adventitial Inflammation Is Increased Beneath Disrupted Atherosclerosis in the Aorta: Implications for Plaque Vulnerability , 2002, Circulation.

[3]  D. Goeddel,et al.  Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.

[4]  Zahi A Fayad,et al.  Atherothrombosis and high-risk plaque: part I: evolving concepts. , 2005, Journal of the American College of Cardiology.

[5]  D. Heistad,et al.  Vasa Vasorum in Atherosclerotic Coronary Arteries: Responses to Vasoactive Stimuli and Regression of Atherosclerosis , 1988, Circulation research.

[6]  I. Vlodavsky,et al.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. , 2001, The Journal of clinical investigation.

[7]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[8]  Ralph Weissleder,et al.  Detection of Vascular Adhesion Molecule-1 Expression Using a Novel Multimodal Nanoparticle , 2005, Circulation research.

[9]  E. Ritman,et al.  Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. , 2001, Cardiovascular Research.

[10]  C. Vlachopoulos,et al.  Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. , 1995, Circulation.

[11]  Renu Virmani,et al.  Intraplaque hemorrhage and progression of coronary atheroma. , 2003, The New England journal of medicine.

[12]  A. Levy,et al.  Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.

[13]  G. Semenza Expression of hypoxia-inducible factor 1: mechanisms and consequences. , 2000, Biochemical pharmacology.

[14]  A. Kurosky,et al.  Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. , 1982, Advances in human genetics.

[15]  Ralph Weissleder,et al.  Seeing Within: Molecular Imaging of the Cardiovascular System , 2004, Circulation research.

[16]  M. Shibuya,et al.  The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. , 2005, Clinical science.

[17]  C. Alpers,et al.  Neovascular expression of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. , 1996, Circulation.

[18]  T. Ohhashi,et al.  Effects of aortic pressure and vasoactive agents on the vascular resistance of the vasa vasorum in canine isolated thoracic aorta. , 1992, The Journal of physiology.

[19]  Chun Yuan,et al.  Quantitative Magnetic Resonance Imaging Analysis of Neovasculature Volume in Carotid Atherosclerotic Plaque , 2003, Circulation.

[20]  G. Gibbons,et al.  The emerging concept of vascular remodeling. , 1994, The New England journal of medicine.

[21]  K. Jablonski,et al.  Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. , 2002, Journal of the American College of Cardiology.

[22]  S. North,et al.  Recent developments in the regulation of the angiogenic switch by cellular stress factors in tumors. , 2005, Cancer letters.

[23]  J. Ehrhardt,et al.  Regulation of blood flow to the aortic media in dogs. , 1978, The Journal of clinical investigation.

[24]  K. Sueishi,et al.  Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. , 1995, Human pathology.

[25]  Mark M. Kockx,et al.  Phagocytosis and Macrophage Activation Associated With Hemorrhagic Microvessels in Human Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[26]  E. Sztul,et al.  Experimentally induced changes in the endocytic traffic of P-glycoprotein alter drug resistance of cancer cells. , 1997, The American journal of physiology.

[27]  V. Fuster,et al.  Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. , 1990, The Journal of clinical investigation.

[28]  D M Shames,et al.  MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. , 2001, Radiology.

[29]  R. Busse,et al.  Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells: Role of the p22phox-Containing NADPH Oxidase , 2001, Circulation research.

[30]  Khawar Gul,et al.  Vasa vasorum imaging: A new window to the clinical detection of vulnerable atherosclerotic plaques , 2005, Current atherosclerosis reports.

[31]  A. Becker,et al.  Leucocyte recruitment in rupture prone regions of lipid-rich plaques: a prominent role for neovascularization? , 1999, Cardiovascular research.

[32]  W. Markiewicz,et al.  Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarction. , 2005, Diabetes.

[33]  A. Kastrati,et al.  Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-year Period after Percutaneous Transluminal Coronary Angioplasty in Individuals with Diabetes , 2022 .

[34]  I. Hochberg,et al.  Haptoglobin phenotype and vascular complications in patients with diabetes. , 2000, The New England journal of medicine.

[35]  P. Carmeliet Angiogenesis in health and disease , 2003, Nature Medicine.

[36]  E L Ritman,et al.  Enhanced coronary vasa vasorum neovascularization in experimental hypercholesterolemia. , 1998, The Journal of clinical investigation.

[37]  A. Levy,et al.  Structure-function analysis of the antioxidant properties of haptoglobin. , 2001, Blood.

[38]  S. Moncada,et al.  Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. , 1989, Atherosclerosis.

[39]  D. Bates,et al.  Vascular endothelial growth factor increases microvascular permeability via a Ca(2+)-dependent pathway. , 1997, The American journal of physiology.

[40]  M. Ferguson,et al.  Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. , 1993, The Journal of clinical investigation.

[41]  S. Moestrup,et al.  CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. , 2002, The international journal of biochemistry & cell biology.

[42]  G. Viale,et al.  Differentiation between high- and low-grade astrocytoma using a human recombinant antibody to the extra domain-B of fibronectin. , 2002, The American journal of pathology.

[43]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[44]  R. Hofer-Warbinek,et al.  The Transcription Factor NF-κB and the Regulation of Vascular Cell Function , 2000 .

[45]  O. Feron,et al.  Innate immunity and angiogenesis. , 2004, Circulation research.

[46]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[47]  V. Bamm,et al.  Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL. , 2004, Biochemistry.

[48]  P. Vallance,et al.  Endothelin alters the reactivity of vasa vasorum: mechanisms and implications for conduit vessel physiology and pathophysiology , 1999, British journal of pharmacology.

[49]  C. Vlachopoulos,et al.  Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. , 1993, Cardiovascular research.

[50]  D. Woolley,et al.  Neovascularization in early atherosclerotic lesions of human carotid arteries: its potential contribution to plaque development. , 1999, Human pathology.

[51]  David Zurakowski,et al.  Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[52]  S. Feinstein,et al.  The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. , 2004, American journal of physiology. Heart and circulatory physiology.

[53]  S. Grundy,et al.  The possible role of the arterial microcirculation in the pathogenesis of atherosclerosis. , 1980, Journal of chronic diseases.

[54]  T. Lüscher,et al.  Molecular Imaging of Atherosclerotic Plaques Using a Human Antibody Against the Extra-Domain B of Fibronectin , 2004, Circulation research.

[55]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[56]  J. Paterson,et al.  Hemosiderin deposition in early atherosclerotic plaques. , 1956, A.M.A. archives of pathology.

[57]  Circulating endothelial progenitor cells and cardiovascular outcomes. , 2005 .

[58]  J. Delanghe,et al.  Biological and clinical significance of haptoglobin polymorphism in humans. , 1996, Clinical chemistry.

[59]  A. Levy Haptoglobin: a major susceptibility gene for diabetic cardiovascular disease. , 2004, The Israel Medical Association journal : IMAJ.

[60]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[61]  R. Beelen,et al.  Regulation of CD163 on human macrophages: cross‐linking of CD163 induces signaling and activation , 1999, Journal of leukocyte biology.

[62]  V. Fuster,et al.  High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[63]  L. Tavazzi,et al.  Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation , 2002, Heart.

[64]  V. Fuster,et al.  New aspects in the pathogenesis of diabetic atherothrombosis. , 2004, Journal of the American College of Cardiology.

[65]  M. Brownlee Biochemistry and molecular cell biology of diabetic complications , 2001, Nature.

[66]  J. Isner,et al.  Cancer and atherosclerosis: the broad mandate of angiogenesis. , 1999, Circulation.

[67]  Yixia Zhang,et al.  Immunohistochemical study of intimal microvessels in coronary atherosclerosis. , 1993, The American journal of pathology.

[68]  D. Schaer The macrophage hemoglobin scavenger receptor (CD163) as a genetically determined disease modifying pathway in atherosclerosis. , 2002, Atherosclerosis.

[69]  M A Konerding,et al.  Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. , 1999, Circulation.

[70]  Samuel A. Wickline,et al.  Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .

[71]  D. Heistad,et al.  Structure and function of vasa vasorum. , 1996, Trends in cardiovascular medicine.

[72]  A. Levy,et al.  Haptoglobin Genotype– and Diabetes-Dependent Differences in Iron-Mediated Oxidative Stress In Vitro and In Vivo , 2005, Circulation research.

[73]  Juan J. Badimon,et al.  Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta: Implications for Plaque Vulnerability , 2004, Circulation.

[74]  V. Fuster,et al.  Lipid Lowering by Simvastatin Induces Regression of Human Atherosclerotic Lesions: Two Years’ Follow-Up by High-Resolution Noninvasive Magnetic Resonance Imaging , 2002, Circulation.